In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…
In May 2002, Governor Hull signed SB 1270 for $5 million over 10 years for genomic research. Later…
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
On Feb. 12, 2002, Pioneer Hi-Bred International made a gift to endow a faculty chair in maize breeding…
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
On Feb. 7, 2002, an assembly of more than fifty leaders and visionaries in science, medicine, government and…
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
On Jan. 4, 2002, The Best Pharmaceuticals for Children Act was signed into law, established a process for…
On Jan. 4, 2002, President George W. Bush signed P.L. 107-109 – S. 1789, the Best Pharmaceuticals for…
In 2002, Stanford researchers became the first to use RNAi to switch off genes in mice.
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
In 2002, the banteng, an endangered species, was cloned for the first time. Bantengs, or Bali cattle (Bos…
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
In 2002, Soy Creations, A Division of Triple ‘F’ Inc, and a corporate partner of Iowa State University’s …
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…